Literature DB >> 14653623

Polymers for induction of revascularization in the rat fascial flap: application of vascular endothelial growth factor and pancreatic islet cells.

Thomas Linn1, Doris Erb, Darius Schneider, Andre Kidszun, A Eser Elçin, Reinhard G Bretzel, Y Murat Elçin.   

Abstract

One of the major obstacles in transplanting avascular tissue or metabolically active cells for ischemic diseases is the loss of transplanted cells due to lack of oxygen and nutrients in the early posttransplantation period. Biodegradable polymeric tissue engineering scaffolds and hydrogels have a potential to incorporate cells or cellular organoids such as islets of Langerhans and growth factors. In this study, we tested the efficiency of two types of polymeric materials to carry recombinant human vascular endothelial growth factor (rhVEGF) or pancreatic tumor cell lines, namely Ins-1 and AR42J, for the induction of new vessels. Chitosan hydrogel fibers with micropores were prepared and molded into a cylinder construct (5 mm phi; 8 mm height). Macroporous PLGA scaffolds with a pore size of 250-400 microm were prepared and cut into cylinders (6 mm phi; 3 mm height). Both chitosan and PLGA constructs were loaded with rhVEGF (3 microg) or seeded with the cell lines (5 x 10(5) cells and 3 x 10(5) cells/construct, respectively, for AR42J and INS-1 cells), and transplanted into the fascial flaps of Wistar rats. At distinct time points up to 4 weeks postimplantation, polymers were explanted, fixed, and vessel density was counted on sections stained with anti-Factor-VIII antibody. Additionally, the kinetics of rhVEGF release from PLGA microspheres (phi of 50-80 microm) was determined using VEGF Elisa. Endogenous VEGF release from pancreatic rat cell lines was also determined. Light microscopy study was performed on H&amp;E-stained paraffin sections of the islet-polymer samples. The vascular density of rhVEGF-loaded chitosan constructs was increased fourfold 2 weeks after subcutaneous transplantation compared with rhVEGF-unloaded controls (465 +/- 144 vs. 104 +/- 80 vessels per mm2, p < 0.05). Protein leakage occurred, but was not observed after 2 weeks. Higher insulin content was detected in rat islet grafts transplanted following VEGF application. More than 50% of total rhVEGF was released on the first day of in vitro culture of PLGA microspheres. rhVEGF secretion had another, but smaller, peak on the third day followed by a constant release. By comparison, endogeneous VEGF secretion of pancreatic tumor cells was measured within a 3-day culture period. Biodegradable polymer scaffolds and hydrogels may have potential use as solid supports to induce angiogenesis for pancreatic cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14653623     DOI: 10.3727/000000003108747244

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  11 in total

Review 1.  Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.

Authors:  T Linn; J Schmitz; I Hauck-Schmalenberger; Y Lai; R G Bretzel; H Brandhorst; D Brandhorst
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

Review 2.  Enhancing clinical islet transplantation through tissue engineering strategies.

Authors:  Jaime A Giraldo; Jessica D Weaver; Cherie L Stabler
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 3.  3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets.

Authors:  Diana Ribeiro; Alexander J Kvist; Pernilla Wittung-Stafshede; Ryan Hicks; Anna Forslöw
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

4.  Osteogenic differentiation of encapsulated rat mesenchymal stem cells inside a rotating microgravity bioreactor: in vitro and in vivo evaluation.

Authors:  Aysel Koç Demir; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Cytotechnology       Date:  2018-06-25       Impact factor: 2.058

Review 5.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

6.  An elastin-based vasculogenic scaffold promotes marginal islet mass engraftment and function at an extrahepatic site.

Authors:  Silvia Minardi; Michelle Guo; Xiaomin Zhang; Xunrong Luo
Journal:  J Immunol Regen Med       Date:  2018-12-10

7.  Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation.

Authors:  Herman Blomeier; Xiaomin Zhang; Christopher Rives; Marcela Brissova; Elizabeth Hughes; Marshall Baker; Alvin C Powers; Dixon B Kaufman; Lonnie D Shea; William L Lowe
Journal:  Transplantation       Date:  2006-08-27       Impact factor: 4.939

Review 8.  Gene expression and silencing for improved islet transplantation.

Authors:  Ram I Mahato
Journal:  J Control Release       Date:  2009-04-17       Impact factor: 9.776

9.  The Optimal Timing for Pancreatic Islet Transplantation into Subcutaneous Scaffolds Assessed by Multimodal Imaging.

Authors:  Andrea Gálisová; Eva Fábryová; Eva Sticová; Lucie Kosinová; Markéta Jirátová; Vít Herynek; Zuzana Berková; Jan Kříž; Milan Hájek; Daniel Jirák
Journal:  Contrast Media Mol Imaging       Date:  2017-12-26       Impact factor: 3.161

Review 10.  Drug releasing systems in cardiovascular tissue engineering.

Authors:  Cristiano Spadaccio; Massimo Chello; Marcella Trombetta; Alberto Rainer; Yoshiya Toyoda; Jorge A Genovese
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.